Brief: Richter Says 2024 Guidance Fully Reiterated

Richter Gedeon Vegyeszeti Gyar Nyrt

14/05/2024 05:16

May 14 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
 GDRB.BU :
    * RICHTER - Q1 2024 HIGHLIGHTS – 2024 GUIDANCE FULLY
REITERATED
    * RICHTER  -  PHARMA REVENUES WERE AT HUF 200BN (EUR 515MN)
IN Q1
2024, UP 13% YOY
    * RICHTER -  Q1 2024 CER CLEAN EBIT AT EUR 178MN (+17%)
    * RICHTER  -  Q1 REVENUES HUF 203,432 MILLION VERSUS HUF
209,653
MILLION
    * RICHTER -  Q1 2024 EBIT (PROFIT FROM OPERATIONS) 63,607
HUF
MILLION VERSUS 54,131 HUF MILLION


Further company coverage:  GDRB.BU 

 ((Reuters.Briefs@thomsonreuters.com;))